VGXI: DNA Science

Future Proof Your Advanced Therapies Supply Chain with VGXI’s US-Based Plasmid CDMO Expertise

In the current landscape of biopharmaceutical drug development, finding a reliable and[…]

  Read More

Five Qualities to Look for in a CDMO

As the biopharmaceutical industry increasingly turns to outsourcing, the key to success lies in[…]

  Read More

VGXI’s Full Spectrum Plasmid DNA Solutions: From Discovery to Commercialization

Plasmids are small, circular, double-stranded DNA molecules that have become indispensable[…]

  Read More

An Introduction to DNA and Vaccines

Vaccines are one of humanity’s most important inventions as they help protect public health[…]

  Read More

VGXI Partner IMM Announces $12M NIH Grant to Support Phase 1 Clinical Trial of a DNA Vaccine for the Prevention of Alzheimer’s Disease

Texas-based CDMO VGXI, Inc. is excited to announce that its partner, The Institute for[…]

  Read More